Cormedix (CRMD)

Add to Watchlists Create an Alert
0.5856 -0.06  -9.49%   AMEX May 23, 8:00PM BATS Real time Currency in USD

Cormedix SG&A Expense Quarterly:

0.1976M for Dec. 31, 2012
View Full Chart

Cormedix SG&A Expense Quarterly Chart

    Cormedix Historical SG&A Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 0.1976M
    Sept. 30, 2012 0.7467M
    June 30, 2012 0.3766M
    March 31, 2012 0.5363M
    Dec. 31, 2011 0.5392M
    Sept. 30, 2011 0.877M
    June 30, 2011 0.898M
    March 31, 2011 0.8345M
       
    Dec. 31, 2010 1.106M
    Sept. 30, 2010 0.6423M
    June 30, 2010 0.6178M
    March 31, 2010 0.6468M
    Dec. 31, 2009 0.0765M
    Sept. 30, 2009 0.3436M
    June 30, 2009 0.3414M
    March 31, 2009 0.4053M

    About SG&A Expense

    SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

    The details of how SG&A expenses are calculated vary widely from company to company, so YCharts recommends looking at the annual report (10-k) an investor is interested in dissecting this number further.
    Learn More

    Get data for

    CRMD SG&A Expense Quarterly Benchmarks

    Companies
    Compugen 1.237M
    ARCA biopharma 0.889M
    Sangamo BioSciences 3.019M

    CRMD SG&A Expense Quarterly Rankings

    Overall 37th percentile
    4980 of 8009
    Sector 10th percentile
    614 of 687 in Healthcare
    Industry 11th percentile
    220 of 248 in Biotechnology

    CRMD SG&A Expense Quarterly Range, Past 5 Years

    Minimum 0.0765M Dec 2009
    Maximum 1.106M Dec 2010
    Average 0.5741M